Akinori Maruta | Health Professions | Best Researcher Award

Published on 07/05/202507/05/2025 by Global Academic Awards

Dr. Akinori Maruta | Health Professions | Best Researcher Award

Dr. Akinori Maruta, Gifu University Hospital/First Department of Internal Medicine, Japan

Dr. Akinori Maruta is a renowned gastroenterologist based in Gifu, Japan. He currently serves at Gifu University Hospital’s First Department of Internal Medicine since 2025. With extensive experience at prominent institutions such as Gifu Prefectural General Medical Center and Gero Onsen Hospital, his expertise spans gastroenterology, hepatology, and endoscopy. He earned his Doctorate in Gastroenterology from Gifu University in 2018. Dr. Maruta holds various certifications, including Specialist and Instructor titles from the Japanese Society of Gastroenterology and the Japan Gastroenterological Endoscopy Society. He also serves as a Supervising Doctor for the Japan Biliary Association and Japan Pancreas Society. 🏥👨‍⚕️📚

Publication Profile

Orcid

Professional Experience 🏥👨‍⚕️

Dr. Akinori Maruta has a distinguished career in gastroenterology, with extensive experience across several leading medical institutions in Japan. He currently serves at Gifu University Hospital in the First Department of Internal Medicine (April 2025-present). Prior to this, he worked at Gifu Prefectural General Medical Center (2018-2025) and Gero Onsen Hospital (2017-2018) in the Department of Gastroenterology. His earlier roles include positions at Gifu University Hospital and Gifu Prefectural General Medical Center (2012-2017), as well as Kizawa Memorial Hospital (2010-2012), where he began as a trainee in 2008. His career reflects a solid progression in clinical practice and expertise.

Education 🎓📚

Dr. Akinori Maruta completed his Doctor of Gastroenterology degree at Gifu University in 2018, where he honed his expertise in the field of gastroenterology. His academic journey began at the Faculty of Medicine, Gifu University, where he graduated in 2008. Throughout his education, Dr. Maruta gained a strong foundation in medical sciences, which laid the groundwork for his successful career in gastroenterology. His educational background from a prestigious institution has been instrumental in shaping his skills and knowledge, supporting his ongoing contributions to the medical field.

Qualifications 🎓

Dr. Akinori Maruta holds several prestigious qualifications in the medical field. He is a General Internal Medicine Specialist certified by the Japanese Society of Internal Medicine. Additionally, he is a Specialist and Instructor for both the Japanese Society of Gastroenterology and the Japan Gastroenterological Endoscopy Society. Dr. Maruta is also a Specialist in the Japan Society of Hepatology. His leadership is further recognized as a Supervising Doctor for both the Japan Biliary Association and the Japan Pancreas Society. These certifications and roles highlight his extensive expertise and contributions to the field of gastroenterology and internal medicine.

Research Focus

Dr. Akinori Maruta’s research primarily focuses on gastroenterology and endoscopic techniques, particularly in the management of biliary and pancreatic disorders. His work includes acute cholangitis, cholecystitis, and malignant biliary obstructions, with an emphasis on endoscopic interventions such as gallbladder stenting, naso-gallbladder drainage, and pancreatic duct stone management. Additionally, Dr. Maruta investigates multicenter cohort studies and propensity score-matched analyses to compare the efficacy of various endoscopic treatments. His contributions to chronic pancreatitis and pancreatic duct stones demonstrate his expertise in advanced endoscopic procedures for gastrointestinal diseases. 🩺🔬🫀

Conclusion

Dr. Akinori Maruta’s extensive professional experience, strong academic credentials, and distinguished qualifications make him a suitable candidate for the “Research for Best Researcher Award.” His contributions to gastroenterology, particularly in endoscopy and hepatology, underscore his expertise and ongoing impact in the medical community.

Publication Top Notes

“One‐stage versus two‐stage endoscopic management for acute cholangitis caused by common bile duct stones: A retrospective multicenter cohort study” – Journal of Hepato-Biliary-Pancreatic Sciences, 2024-06, DOI: 10.1002/jhbp.1431 🔬🩺
“Comparison of unilateral and bilateral intraductal plastic stent placement for unresectable malignant hilar biliary obstruction: A propensity score‐matched cohort analysis” – Journal of Hepato-Biliary-Pancreatic Sciences, 2024-04, DOI: 10.1002/jhbp.1399 📊🩺
“Peroral Pancreatoscopy-Guided Lithotripsy Compared with Extracorporeal Shock Wave Lithotripsy in the Management of Pancreatic Duct Stones in Chronic Pancreatitis: A Multicenter Retrospective Cohort Study” – Diagnostics, 2024-04-24, DOI: 10.3390/diagnostics14090891 🔬💡
“Endoscopic internalization by cutting versus removal of the endoscopic transpapillary naso‐gallbladder drainage tube in preoperative management of acute cholecystitis: A retrospective multicenter cohort study” – Journal of Hepato-Biliary-Pancreatic Sciences, 2023-09, DOI: 10.1002/jhbp.1344 🏥💉
“Endoscopic Internalization by Cutting the Endoscopic Transpapillary Nasogallbladder Drainage Tube in Management of Acute Cholecystitis: A Retrospective Multicenter Cohort Study” – Journal of Clinical Medicine, 2022-12-14, DOI: 10.3390/jcm11247415 📚🔬
“Permanent endoscopic gallbladder stenting versus removal of gallbladder drainage, long‐term outcomes after management of acute cholecystitis in high‐risk surgical patients for cholecystectomy: Multi‐center retrospective cohort study” – Journal of Hepato-Biliary-Pancreatic Sciences, 2021-12, DOI: 10.1002/jhbp.967 📅🩺
“Factors affecting technical success of endoscopic transpapillary gallbladder drainage for acute cholecystitis” – Journal of Hepato-Biliary-Pancreatic Sciences, 2020-07, DOI: 10.1002/jhbp.744 🔬⚙️
Efficacy of mapping biopsy using a novel sheath system for the histological diagnosis of superficial ductal spread in distal cholangiocarcinoma: A retrospective multicenter study
Endoscopic management of acute cholecystitis in high‐risk surgical patients: A comprehensive review article

Zhushanying Zhang | Health Professions | Best Researcher Award

Published on 20/11/202420/11/2024 by Global Academic Awards

Assist. Prof. Dr. Zhushanying Zhang | Health Professions | Best Researcher Award

Assist. Prof. Dr. Zhushanying Zhang, South-Central Minzu University, China

Dr. Zhushanying Zhang holds a Ph.D. in Mechanical and Electronic Engineering from the School of Mechanical Science and Engineering, Huazhong University of Science and Technology. His research focuses on infrared spectroscopy detection, machine learning, optoelectronic detection, and fiber optic sensing. Dr. Zhang has led multiple National Natural Science Foundation of China-funded projects and received special funding for basic scientific research. He has published over ten academic papers and holds three invention patents. His work includes advancing Fourier infrared spectroscopy for noninvasive diabetes diagnosis through blood, urine, and saliva samples. 🔬📑💡

Publication Profile

Scopus

Academic and Professional Background

Assist. Prof. Dr. Zhushanying Zhang graduated with a Ph.D. in Mechanical and Electronic Engineering from the School of Mechanical Science and Engineering at Huazhong University of Science and Technology. His research focuses on infrared spectroscopy detection, machine learning, optoelectronic detection, and fiber optic sensing. Dr. Zhang has led and participated in several research projects funded by the National Natural Science Foundation of China, alongside special funding for basic scientific research from central universities. He has published over ten high-quality academic papers as the first or corresponding author and holds three invention patents. 📚💡📑

Research and Innovations

Assist. Prof. Dr. Zhushanying Zhang has led multiple innovative research projects focused on non-invasive detection technologies. His completed projects include the “Highly Accurate Glucose Detection Using Mid-Infrared Absorption Spectroscopy” (2022-2023, 50,000 Yuan) and “Non-invasive Uric Acid Detection by Near-Infrared Spectroscopy” (2018-2020, 40,000 Yuan), both funded by the Fundamental Research Funds for Central Universities. He also presided over the “Non-invasive Detector for Human Weak Components” (2021-2023, 100,000 Yuan) and “Human Saliva Infrared Spectroscopy Detection” (2022-2023, 500,000 Yuan). His work in Fourier infrared spectroscopy offers promising advancements for diabetes diagnosis using blood, urine, and saliva samples. 🧬📊

Research Areas

Assist. Prof. Dr. Zhushanying Zhang’s research spans across multiple cutting-edge fields. His expertise in infrared spectroscopy and fiber optic sensing focuses on non-invasive medical diagnostics, particularly for glucose and uric acid detection. Utilizing machine learning techniques, he enhances the accuracy and efficiency of sensor data analysis. His work in medical sensing aims to revolutionize healthcare by developing innovative detection technologies. Additionally, Dr. Zhang applies chemometrics to optimize data interpretation, advancing the potential of these technologies for real-world applications, especially in diagnostics and healthcare monitoring. 🔍💡📈

Publication Top Notes

“Advances in Fourier infrared spectroscopy for noninvasive diagnosis of diabetes mellitus: Analysis and prospects for application based on blood, urine, and saliva samples” (2024) 📄
“Precise measurement of human heart rate based on multi-channel radar data fusion” (2024) 📄
“A comprehensively improved local binary pattern framework for texture classification” (2024) 📄
“Identifying the Role of Disulfidptosis in Endometrial Cancer via Machine Learning Methods” (2023) 📄 | Cited by 1
“Quantitative Analysis of Hemoglobin Based on SiPLS-BP Model” (2023) 📄 | Cited by 2
“Texture classification combining improved local binary pattern and threshold segmentation” (2023) 📄 | Cited by 12
“Mid-infrared spectroscopy with an effective variable selection method based on MPA for glucose detection” (2023) 📄 | Cited by 5
“Influencing Factors of Mid-Infrared Spectrum Blood Glucose Detection” (2023) 📄 | Cited by 2
“Quantitative Analysis of Hemoglobin Based on SiPLS-SPA Wavelength Optimization” (2023) 📄 | Cited by 3
“Thermal performance of LED filament in flip-chip packaging manufactured for different correlated color temperature” (2021) 📄 | Cited by 1

Fei Yu | Medicine and Dentistry | Best Researcher Award

Published on 29/10/202429/10/2024 by Global Academic Awards

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.

Min-ran Li | Medicine and Dentistry | Women Researcher Award

Published on 17/10/202417/10/2024 by Global Academic Awards

Ms. Min-ran Li | Medicine and Dentistry | Women Researcher Award

Ms. Min-ran Li, The First Affiliated Hospital of Jinan University, China

Dr. Minran Li is the Chief Physician at the Division of Infectious Disease at The First Affiliated Hospital of Jinan University. He earned his M.D. in Internal Medicine from Peking University and has extensive expertise in infectious diseases, particularly nonalcoholic steatohepatitis (NASH) and chronic hepatitis B. His research focuses on discovering noninvasive biomarkers and the molecular mechanisms behind liver diseases. Dr. Li has published numerous articles and has been recognized as a Guangdong High-Level Personnel of Young Talents. 🏥📚

Publication Profile

Scopus

Education

Ms. Li holds an M.D. in Internal Medicine (Infectious Disease) from Beijing Peking University, a Master’s in Internal Medicine from Hebei Medical University, and a Bachelor’s in Clinical Medicine. This strong educational foundation has empowered her expertise in infectious diseases, particularly liver-related conditions like NASH (nonalcoholic steatohepatitis) and CHB (chronic hepatitis B).

Work Experience

Currently serving as Chief Physician in the Division of Infectious Diseases at the First Affiliated Hospital of Jinan University, Ms. Li has progressively taken on roles of increasing responsibility, including as Associate Chief Physician at The Fifth Hospital of Shijiazhuang. Her work centers on managing liver diseases and exploring innovative biomarkers.

Research Interests

Her research focuses on discovering noninvasive biomarkers for pathological features of NASH in combination with CHB. Her findings on the role of HIGD1A and fibrosis development in liver disease have been pivotal in identifying therapeutic targets, advancing the understanding of liver disease progression.

Awards and Recognitions

Her dedication has been recognized with honors such as the Guangdong High-Level Personnel of Young Talents Program and the Yangcheng Good Doctor Award, underscoring her excellence in medical research and practice.

Conclusion

Ms. Min-ran Li’s strong academic background, leadership in liver disease research, and national and international recognition make her a strong candidate for the Research for Women Researcher Award.

Publication Top Notes

Pan, Y. et al. (2024). Overexpression of LAG-3: a potential indicator of low immune function in tuberculosis. Frontiers in Cellular and Infection Microbiology, 14, 1410015. 🦠 (0 citations)
Li, M.-R. et al. (2024). The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis B. Scandinavian Journal of Gastroenterology, 59(4), 445–455. 🥗 (0 citations)
Li, J.-Z. et al. (2023). Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis. Molecules, 28(23), 7936. 🌿 (0 citations)
Li, M.-R. et al. (2023). Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population. Obesity Facts, 16(5), 427–434. 🍔 (1 citation)
Pan, Y. et al. (2023). Immune checkpoint inhibitors in cancer patients with COVID-19. Open Life Sciences, 18(1), 20220641. 💉 (1 citation)
Li, J.-Z. et al. (2022). Characteristics and treatment strategies for hepatocellular carcinoma caused by nonalcoholic fatty liver disease. Zhonghua gan zang bing za zhi, 30(12), 1392–1396. 🏥 (0 citations)
Yang, L. et al. (2022). Progress in research of lipogenesis inhibitors for treatment of nonalcoholic fatty liver disease. World Chinese Journal of Digestology, 30(16), 735–742. 🧬 (1 citation)
Li, J.-Z. et al. (2021). The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. Virus Research, 298, 198405. 🔬 (20 citations)
Zheng, X.-L. et al. (2021). Effect of optimizing oxygen therapy on multiple organ function and prognosis of patients with COVID-19. Chinese Journal of Pathophysiology, 37(5), 909–914. 🫁 (0 citations)
Li, M.-R. et al. (2020). Clinical features of hepatitis B patients at immune-tolerance phase with basal core promoter and/or precore mutations. Journal of Viral Hepatitis, 27(10), 1044–1051. 🦠 (4 citations)

James Melrose | Health Professions | Best Researcher Award

Published on 29/08/202429/08/2024 by Global Academic Awards

Prof. James Melrose | Health Professions | Best Researcher Award

Prof. James Melrose, The University of Sydney, Australia

Based on the provided information, Prof. James Melrose appears to be a highly suitable candidate for the Research for Best Researcher Award. Here’s an evaluation of his qualifications:

Publication profile

Google Scholar

Academic and Research Excellence

Prof. Melrose has a solid educational background with a B.Sc (Hons) in Biochemistry and a Ph.D. focused on carbohydrate metabolizing enzymes associated with barley. His long-standing affiliation with prestigious institutions such as The University of Sydney and the University of New South Wales highlights his strong academic and research credentials. Over a period of three decades, he has contributed significantly to bone and joint research, particularly in biochemical and immunological studies.

Special Awards and Recognitions

Prof. Melrose has received numerous prestigious awards throughout his career, demonstrating his recognition by the scientific community. Notable awards include the Smith and Nephew Award for his work on the spine, the Matrix Biology Society’s best poster award, and the European Spine Society’s GRAMMER Award. These accolades emphasize his contributions to the field of spine research and matrix biology, marking him as a leading researcher.

Teaching and Mentorship

Prof. Melrose has a strong background in teaching and mentorship, having served as a laboratory demonstrator, lecturer, and co-supervisor of Ph.D. students. His involvement in training and supervising research personnel at the Raymond Purves Bone and Joint Research Laboratories underscores his commitment to education and nurturing the next generation of researchers. This combination of research and teaching excellence enhances his candidacy for the award.

Publication Top Notes

📚 “Are animal models useful for studying human disc disorders/degeneration?”
- European Spine Journal 17, 2-19
- Cited by: 854
- Year: 2008
📘 “Diverse cell signaling events modulated by perlecan”
- Biochemistry 47 (43), 11174-11183
- Cited by: 319
- Year: 2008
🔬 “Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration”
- Spine 27 (12), 1278-1285
- Cited by: 255
- Year: 2002
🧬 “Proteoglycan degradation by the ADAMTS family of proteinases”
- Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (12)
- Cited by: 249
- Year: 2011
🔍 “Keratan sulfate, a complex glycosaminoglycan with unique functional capability”
- Glycobiology 28 (4), 182-206
- Cited by: 226
- Year: 2018
🦴 “Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis”
- Arthritis research & therapy 8, 1-6
- Cited by: 200
- Year: 2006
💉 “Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors”
- Journal of Biological Chemistry 277 (17), 14657-14665
- Cited by: 200
- Year: 2002
🔗 “A comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) proteoglycans of the…”
- The Journal of Anatomy 198 (1), 3-15
- Cited by: 194
- Year: 2001
🧠 “Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms”
- Journal of vascular surgery 24 (1), 82-92
- Cited by: 173
- Year: 1996
📈 “Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study”
- Histochemistry and cell biology 124, 225-235
- Cited by: 164
- Year: 2005

Conclusion

Prof. James Melrose’s extensive research experience, numerous awards, and significant contributions to biochemistry and spine research make him a highly deserving candidate for the Research for Best Researcher Award. His roles in teaching and mentoring further solidify his position as a leader in his field, making a lasting impact on both research and education.

Dan Yan | Medicine and Dentistry | Best Researcher Award

Published on 10/06/202410/06/2024 by Global Academic Awards

Dan Yan | Medicine and Dentistry | Best Researcher Award

Prof Dan Yan,Beijing Friendship Hospital, Capital Medical University,China

Prof. Dan Yan, Ph.D., is a leading figure in clinical pharmacy and precision medicine at Beijing Institute of Clinical Pharmacy, China. 🌟 With a robust background in traditional Chinese medicine and a Ph.D. from Chengdu University, he specializes in intelligent molecular diagnosis and combined medication for chronic metabolic diseases. 🧬 His groundbreaking research focuses on optimizing diabetes treatment, particularly exploring multi-drug combinations and personalized therapies. As a prolific author and committee member of prestigious scientific organizations, Prof. Yan is dedicated to advancing healthcare through innovative research and evidence-based practices. 📚✨

Publication profile

Scopus

Education

Prof. Dan Yan pursued an extensive educational journey at Chengdu University of Traditional Chinese Medicine, culminating in a Ph.D. from 2004 to 2007. Prior to his doctoral studies, he obtained his Master of Science degree from the same institution between 2001 and 2004. Prof. Yan’s academic pursuits trace back to his undergraduate years, where he completed his Bachelor of Science degree from 1994 to 1998, laying the foundation for his subsequent advanced studies. His educational background reflects a dedicated commitment to traditional Chinese medicine, fostering a deep expertise in this field.

Research focus

Prof. Dan Yan’s research focuses on the intelligent molecular diagnosis and combined medication for chronic metabolic diseases, particularly pre-diabetes and type 2 diabetes. His work leverages multi-omics approaches, such as metabolomics, to enhance early diagnosis and personalized treatment strategies. He aims to optimize drug combinations from a broad range of hypoglycemic drugs, including traditional and novel therapies. This research not only addresses the declining efficacy of long-term metformin use but also integrates pharmacoeconomics and evidence-based medicine to improve clinical outcomes in diabetes care.